Effective for dates of service on and after June 1, 2020, Anthem Blue Cross will include the specialty pharmacy drugs and corresponding codes from current clinical criteria noted below in our medical step therapy precertification review process. Step therapy review applies upon precertification initiation or renewal in addition to the current medical necessity review (as is done currently).


The clinical criteria below have been updated to include the requirement of a preferred agent effective June 1, 2020.

Clinical criteria

Preferred drug

Nonpreferred drug


Retacrit (Q5106)

Procrit (J0885)


Zarxio (Q5101)

Neupogen (J1442), Granix (J1447) and Nivestym (Q5110)

The clinical criteria is publicly available on our provider website. Visit the Clinical Criteria website to search for specific clinical criteria.


What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local Provider Relations representative or call one of our Medi-Cal Customer Care Centers at 1‑800‑407‑4627 (outside L.A. County) or 1‑888‑285‑7801 (inside L.A. County).

Featured In:
April 2020 Anthem Blue Cross Provider News - California